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1. Introduction
  Hepatocellular carcinoma (HCC) is one of commonest 
malignant tumors, its pathogenesis is still not completely 
clear, and its morbidity is rising year by year in China. 
Because of its high morbidity and poor prognosis, it is hot 
spot research to discover the molecular mechanism for HCC 
metastasis. G protein-coupled receptor kinase 6 (GRK6) is 
an important protein kinase in human, which participates 
in the pathological process of many diseases[1-5]. GRK6 
can regulates the activity of chemokine receptor by 
phosphorylation[6,7] , and is related to the adhesion and 
movement of many cancer cell lines. It is reported that 
the lack of GRK6 can inhibit cancer cell migration[8]. The 
function and expression of GRK6 in HCC has not been 
reported. This study is to determine GRK6 expression in 
HCC by immunohistochemical assay and Western blot, and 
to analyze the relationship between the expression level and 
clinicopathological features of HCC.
2. Materials and methods
2.1. Material
  A total of 73 HCC samples were collected from patients 
admitted from May 2010 to August 2011, and all samples 
were confirmed by pathological histological analysis. 
The age was 34 to 75 years old, averaged 53 years old; it 
included male 50, female 2; 栺 grade 24, 栻 grade 36, 栿
grade 13 (Table 1). All patients had informed consent. The 
material from the operation was equally divided into two 
copies, one was fixed with formaldehyde, embedded with 
paraffin, and used for immuohistochemical stainin, and 
another one was preserved in cryogenic refrigerator under - 
80 ℃ after liquid nitrogen frozen for Western blot.
  GRK6 antibody from rabbits and 毬-actin antibody from 
rats were from Santa cruz Company, chemiluminescent 
solution was supplied by CST company, SP kit was from 
Dako, and the other chemical reagent was analytical reagent 
made in china.
2.2. Method
2.2.1. Immuohistochemical assay 
  SP method was performed. The paraffin section was under 
conventional dewaxing, incubated in room temperature 
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in 3% methanol solution for 15 min, washed 3 times with 
PBS, closed with normal goat serum working solution for 1 
h, and then incubated in GRK6 antibody at 4 ℃ for a night. 
Then the sections was rinsed in PBS, incubated in room 
temperature for 30 min, developed by DAB, stained by 
hematoxylin, dehydrated by ethanol, transparented and fixed 
by neutral xylene balata. GRK6 expression was observed 
and analyzed under light microscope, and was presented 
by positive cell percentage. Antibody dilution ratio of GRK6 
was 1:200.
2.2.2. Western blot assay
  Histiocyte lysate was prepared in 100 mg/mL, including 1 M
Tris-HCl pH 7.5, 1% TritonX-100, 1% NP-40, 10% SDS, 0.5% 
sodium deoxycholate, 0.5 M EDTA, 10 毺g/mL leupeptin, 
10 毺g/mL aprotinin, 1 mm PMSF, 40 mmol/L DTT and 
deionized water. And then histiocyte lysate was kept in ice 
for 1h, centrifuged in 4 ℃ at 12 000 r/min for 20 min. Upper 
homogenate was tabken for Bradford test, and kept in -80 ℃ 
for reserve. The total protein was degenerated for 10 min 
under boiling and analyzed in SDS PAGE gel. After then the 
protein was diverted with electro transfer from SDS PAGE 
gel to PVDF membrane. After washed with TBST, PVDF 
membrane was temperature closed in TBST with 5% defatted 
milk powder, and added once with antibody (rabbit anti 
human GRK6 1:1 000), incubated in 4 ℃ for a night, washed 
with TBST 3 times and then added twice with antibody 
(horse radish peroxidase marked goat anti-rabbit IgG,
1:1 000), incubated in room temperature for 2 h, fondly 
washed with TBST 3 times (10 min), developed in ECL color. 
GRK6 expression was presented by ratio of banding gray 
value of GRK6 and 毬-actin.
2.3. Statistical analysis 
  All statistical analyses were carried out with SPSS 13.0 
statistical software. 氈
2 test was used for GRK6 expression, 
and Spearman correlation analysis was used for clinical 
index correlation. The survival rate acquired from follow-
up visit was analyzed with Kaplan Meier survival curve and 
Single variable Log rank test. Statistical significance was set 
at P<0.05.
3. Result 
3.1. GRK6 expression on HCC tissue and pericarcinomatous 
tissue 
  Immunohistochemical result shows that the expression 
of GRK6 and Ki67 in HCC tissue was significantly higher 
than that in pericarcinomatous tissue (Z = -2.422, P < 0.05) 
(Figure 1). Western blot test was performed for the GRK6 
expression in fresh tissue, and the outcome shows there was 
a specific banding in 66 kD, whose molecular weight was the 
same with GRK6, indicating the GRK6 expression. Figure 
2 shows the GRK6 expression in pericarcinomatous tissue 
was significantly lower (0.14依 0.02) than in HCC tissue (0.79依 
0.21) (P < 0.05).
 
Figure 1. Expression of GRK6 and Ki-67 (SP × 200).
A: GRK6 expression in pericarcinomatous tissue; B: GRK6 expression 
in HCC tissue; C: Ki-67 expression in pericarcinomatous tissue; D: 
Ki-67 expression in HCC tissue.
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Figure 2. GRK6 expression in carcinoma tissue (T) and in 
pericarcinomatous tissue (N).
3.2.  Relat ionship  between GRK6 express ion and 
clinicopathological features
  GRK6 expression was related to age, sex, the size of tumor, 
hard state, AFP and HBeAb. GRK6 expression in poor-
differentiated carcinoma tissue was significantly higher than 
that in high-differentiated (P = 0.005). And that in tumor 
metastasis carcinoma tissue was significantly higher than 
that in not metastasis (P = 0.045). Ki-67 was a index for 
tumor cell proliferation, whose expression was linear related 
to GRK6 expression (Figure 3).
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Table 1
Relationship between GRK6 expression and clinic opathological 
features.
Parameters Total
GRK6
P
Low≤ 0.46 High>0.46
Age (years)
≤ 45 30 14 16 0.235
>45 43 14 29
Gender
Male 50 21 29 0.440
Female 23   7 16
Histological grade
Well 24 13 11 0.005
Mod 36 15 21
Poor 13   0 13
Metastasis
Positive 46 22 24 0.045
Negative 27   6 21
Tumor size (cm)
≤ 5 57 21 36 0.772
>5 16   7   9
Cirrhosis
Positive 23 10 13 0.841
Negative 50 23 27
AFP (ng/mL)
≤ 50 57 26 31 0.895
>50 16   7   9
HbSAg
(+) 57 46 11 0.056
(-) 16   9   7
100.00
80.00
60.00
40.00
20.00
ki
67
20.00              40.00               60.00              80.00              100.00
r2=0.751
GRK6
 
Figure 3.  Linear relationship between the expression in Ki-67 and 
GRK6.
3.3. Influence of GRK6 expression on survival after operation
  Survival data of 52 cases was collected from 73 cases, 
including 33 patients with high GRK6 expression and 19 
patients with low GRK6 expression. Survival rate of high 
GRK6 expression group was 39.4%, and low group was 78.9%. 
The result shows that GRK6 expression (P = 0.009), Ki-67 
expression (P = 0.009) and histilogical grade were correlated 
with survival (Table 2). Survival analysis and single variable 
log rank test showed that the higher was, the lower survival 
rates was (氈
2 = 4.821, P<0.05); and the shorter survival time 
was, the worse prognosis was (Figure 4).
Table 2
Survival analysis of patients. 
Total
Survival status
P
Dead Alive
Age (years)
≤ 45 19 9 14 0.412
>45 33 15 14
Gender
Male 19 13   6 0.021
Female 33 11 22
Histological grade
Well 13   6   7 0.045
Mod 17   4 13
Poor 22 14   8
Metastasis
Positive 31   9 22 0.004
Negative 21 15   6
Tumor size (cm)
≤ 5 39 19 20 0.749
>5 13   5   8
Cirrhosis
Positive 19 14   5 0.868
Negative 33 25   8
AFP (ng/mL)
≤ 50 39 20 19 0.528
>50 13   5   8
HbSAg
(+) 33 18 15 0.219
(-) 19   7 12
Ki-67
Low expression 24   4 20 0.000
High expression 28 20   8
GRK6
Low expression 19   4 15 0.009
High expression 33 20 13
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Figure 4. Relationship between GRK6 expression and survival rate 
after surgery.
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4. Discussion 
  HCC has high malignant degree and morbidity, and 
postoperative recurrence and metastasis are the important 
factors of prognosis. The metastasis of the HCC is a multiple 
stage process. The first display of HCC cell is abating 
adhesivity and enhancing athletic ability, and secretes 
substances such as matrix metalloproteinase to degrade 
extracellular matrix and then the HCC cell can cross through 
the basement membrane and extracellular matrix[9-12]. The 
metastasis of the HCC cell to a great extent depends on the 
signal and the function of the chemokine[13,14].
  GRK6 belongs to GRKs family. The member of GRKs 
contains a high conserved regulator of G protein signaling 
protein domain, a Ser-Thr kinase domain which is similar 
to AGC protein kinase domain, and a carboxyl terminal 
which is affected with cell membrane[15]. In addition to 
mediate phosphorylation dependent desensitization effect of 
G protein coupled receptor, GRKs still can phosphorylation 
regulate other substrate. The reaserch shows that GRKs is 
closly related to the movement and migration of the cell, 
participates in cell movement and cell migration of the 
integin[16], and participate in the regulation of chemotaxis T/
B cell and neutrophil[17]. GRK6 is related to the adhere and 
movement of many kinds cancer cell, and it can disturb and 
significantly inhibit the migration of PC3, MB231 and Hela 
cell. GRK6 interacted with GRK-interacting protein (GIT1) 
adjust the cell adhere and cytoskeleton reconstruction[8,18]. 
In addition, GRK6 can affect the migration and invasion 
of cancer cell through second messenger such as cAMP, 
calmodulin and EGFR[19, 20].
  This study found that GRK6 is high expressed in HCC, and 
related to the migration and prognosis of HCC. Determining 
GRK6 expression can help early diagnosis of HCC and to 
evaluate the prognosis of the patients. GRK6 may participate 
in the regulation for migration and invasion of HCC cell, but 
the molecular mechanism is still needed further research.
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